Muscular Dystrophy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with LAMA2-related muscular dystrophy, confirmed by either: two specific gene changes (mutations) in the LAMA2 gene, OR a muscle biopsy showing absence of a protein called merosin along with at least one LAMA2 gene mutation, OR a matching set of symptoms and a sibling who meets one of the above criteria
- You are able to attend study visits at least once every 12 months over a 24-month period
- You (if an adult) are able to sign a consent form, or your parent or legal guardian is able to sign on your behalf (if you are a child)
Who may not be able to join:
- You do not have a confirmed diagnosis of LAMA2-related muscular dystrophy
- You are unable to attend study visits at least once every 12 months
- Your health condition makes it unsafe for you to travel to the study site or take part in the study assessments
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +390226435080
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Rhythm abnormalities; Cardiac function; Cardiac inflammation and fibrosis
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.